Ramiro Guerrero, Director at MAIA Biotechnology, Inc. (MAIA), bought 60 shares at $4.25 ($255) on 2023-02-17, disclosed to the SEC on 2023-02-21.
Scheduled purchase ($255) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.25 | 10 | $43 | 16.7% |
| 2 | $4.25 | 50 | $213 | 83.3% |
| Total | $4.25 avg | 60 | $255 | 100% |
| Filing → |
| MAIA | BUY | 2026-08-26 | $2K | — | Filing → |
| MAIA | BUY | 2026-08-24 | $16K | — | Filing → |
| MAIA | BUY | 2025-05-12 | $30K | — | Filing → |